Cerebral Edema in Patients with severe Hemispheric Syndrome: Incidence, Risk Factors, and Outcomes-Data from SITS-ISTR.

"Disclosure: Niaz Ahmed is the Chairman of SITS International, which receives a grant from Boehringer Ingelheim for the SITS-International Stroke Thrombolysis Register and from Stryker, Covidien, and Phenox in collaboration with Karolinska Institutet for the SITS-OPEN study. Shih-Yin Chen is an employee of Biogen and owns stock in Biogen. Nicole Tsao was an employee of Biogen at the time of the study and owns stock in Biogen. This study was funded by Biogen. Other authors have no disclosures regarding conflict of interest."

"SITS is financed directly and indirectly by grants from Karolinska Institutet, Stockholm County Council, the Swedish Heart- Lung Foundation, the Swedish Order of St. John, Friends of Karolinska Institutet, and private donors, as well as from an unrestricted sponsorship from Boehringer-Ingelheim. SITS has previously received grants from the European Union Framework 7, the European Union Public Health Authority, Ferrer International and EVER Pharma. SITS is currently conducting studies supported by Boehringer-Ingelheim and Biogen, as well as in collaboration with Karolinska Institutet, supported by Stryker, Covidien, and Phenox. Niaz Ahmed is supported by grants provided by the Stockholm County Council and the Swedish Heart-Lung Foundation. S Holmin is supported by grants provided by the Söderberg Foundations, the Stockholm County Council, the Erling Persson Foundation, VINNOVA, and HMT. Irene Escudero-Martínez has received a grant from “Fundación Progreso y Salud, Junta de Andalucía” (grant EF-0437- 2018). Magnus Thorén has received grants or funding from Stiftelsen Tornspiran, Stiftelsen Sigurd och Elsa Goljes Minne, STROKE-Riksförbundet, Capio forskningsstiftelse, and Karolinska University Hospital. Disclosure: Niaz Ahmed is the Chairman of SITS International, which receives a grant from Boehringer Ingelheim for the SITS-International Stroke Thrombolysis Register and from Stryker, Covidien, and Phenox in collaboration with Karolinska Institutet for the SITS-OPEN study. Shih-Yin Chen is an employee of Biogen and owns stock in Biogen. Nicole Tsao was an employee of Biogen at the time of the study and owns stock in Biogen. This study was funded by Biogen. Other authors have no disclosures regarding conflict of interest."